116
Participants
Start Date
July 4, 2012
Primary Completion Date
July 22, 2016
Study Completion Date
October 31, 2018
Carfilzomib
Carfilzomib was administered as a 30-minute IV infusion on days 1, 8, and 15 of each 28-day treatment cycle.
Dexamethasone
Dexamethasone was administered at a dose of 40 mg IV or orally (PO) on days 1, 8, 15, and 22 for the first 8 cycles; starting with cycle 9 dexamethasone was administered on days 1, 8, and 15.
Arizona Oncology Associates, Tucson
Comprehensive Blood and Cancer Center (CCBC), Bakersfield
California Cancer Associates for Research and Excellence, Encinitas
Robert A. Moss, M.D., FACP, Inc., Fountain Valley
California Cancer Associates for Research and Excellence, Fresno
Cedars-Sinai Medical Center, Los Angeles
Monterey Bay Oncology, Salinas
Sansum Clinic, Santa Barbara
Central Coast Medical Oncology Corporation, Santa Maria
James R. Berenson M.D. Inc., West Hollywood
The Oncology Insititute of Hope and Innovation, Whittier
Rocky Mountain Cancer Centers, Denver
Florida Cancer Specialists - South, Fort Myers
Florida Cancer Specialists - North, Tampa
Illinois Cancer Care, Galesburg
Illinois Cancer Specialists, Hinsdale
Illinois Cancer Specialists, Niles
Fort Wayne Oncology & Hematology, Fort Wayne
Horizon Oncology Research, Inc., Lafayette
Center for Cancer and Blood Disorders (CCBD), Bethesda
Hematology-Oncology Associates of Northern NJ, PA, Morristown
New Mexico Cancer Care Alliance, Albuquerque
Clinical Research Alliance, New York
Hudson Valley Hematology Oncology Associates, Poughkeepsie
Willamette Valley Cancer Institute and Research Center, Eugene
Tennessee Oncology, PLLC, Chattanooga
St. Joseph Regional Cancer Center, Bryan
Millennium Oncology, Houston
Waldron Medical Research and Development Center, Houston
Cancer Care Centers of South Texas, San Antonio
Center at Cancer Therapy & Research Center at The University of Texas Health Science Center at San Antonio, San Antonio
Blood and Cancer Center of East Texas, Tyler
Shenandoah Oncology, PC, Winchester
Northwest Cancer Specialists, Vancouver
Yakima Valley Memorial Hospital/ North Star Lodge, Yakima
Lead Sponsor
Amgen
INDUSTRY